Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bismuth + magnesium refers to a combination of the elements bismuth and magnesium, which may be present together in certain pharmaceutical formulations or as a chemical mixture. Bismuth compounds are commonly used for their antidiarrheal, gastroprotective, and antimicrobial properties in the gastrointestinal tract. Magnesium compounds (such as magnesium carbonate or trisilicate) are often included for their antacid effects and ability to neutralize stomach acid. Combination products containing both bismuth and magnesium salts have been developed primarily for the treatment of gastric and duodenal ulcers, chronic gastritis, indigestion, heartburn, diarrhea, and other gastrointestinal discomforts. The mechanism of action involves local protection of the gastric mucosa by forming protective barriers (bismuth salts), reducing inflammation (bismuth), neutralizing excess stomach acid (magnesium salts), and providing mild antimicrobial activity against pathogens such as Helicobacter pylori[9][1]. These combinations may also include additional ingredients depending on formulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bismuth + magnesium.